Evaluación clínica del buflomedil en pacientes adultos con síndrome demencial

García Ramos, Guillermo; Siliceo, Enrique Otero; Escobedo Ríos, Francisco; François, Hughes; Carballo, Carmen.
Invest. med. int ; 12(3): 208-15, oct. 1985. tab
Artigo em Espanhol | LILACS | ID: lil-27586

Documentos relacionados

  1. Efficacy of Vincamine treatment in a rat model of anterior ischemic optic neuropathy.
  2. Vincamine as an agonist of G-protein-coupled receptor 40 effectively ameliorates diabetic peripheral neuropathy in mice.
  3. Screening potential anaphylactoid components in vinpocetine injection using a high expression Mas-related G-protein-coupled receptor X2 cell membrane chromatography.
  4. Disease-Modifying Effects of Vincamine Supplementation in <i>Drosophila</i> and Human Cell Models of Parkinson's Disease Based on <i>DJ-1</i> Deficiency.
  5. WITHDRAWN: Interventions for normal tension glaucoma.
  6. ALK and ERBB2 Protein Inhibition is Involved in the Prevention of Lung Cancer Development by Vincamine.
  7. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
  8. Alpneumines A-H, new anti-melanogenic indole alkaloids from Alstonia pneumatophora.
  9. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
  10. Vincamine, an active constituent of Vinca rosea ameliorates experimentally induced acute lung injury in Swiss albino mice through modulation of Nrf-2/NF-&#954;B signaling cascade.